2023
DOI: 10.1093/europace/euad013
|View full text |Cite
|
Sign up to set email alerts
|

Pulse arrival time variation as a non-invasive marker of acute response to cardiac resynchronization therapy

Abstract: Aims Successful cardiac resynchronization therapy (CRT) shortens the pre-ejection period (PEP) which is prolonged in the left bundle branch block (LBBB). In a combined animal and patient study, we investigated if changes in the pulse arrival time (PAT) could be used to measure acute changes in PEP during CRT implantation and hence be used to evaluate acute CRT response non-invasively and in real time. Methods and results In s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…All these investigations have potential translational impact for further optimization of re-synchronization therapies. How the efficacy of such therapies can be evaluated best has also been studied in-depth, with the LV end-systolic volume, 12 the so-called heart-arterial coupling 13 and the pulse arrival time (the time the pulse waves need to travel from the LV to the lower limb 14 ) as potential markers of an acute response to cardiac re-synchronization therapy in experimental studies. These results require further clinical validation.…”
Section: Pacing and Ablationmentioning
confidence: 99%
“…All these investigations have potential translational impact for further optimization of re-synchronization therapies. How the efficacy of such therapies can be evaluated best has also been studied in-depth, with the LV end-systolic volume, 12 the so-called heart-arterial coupling 13 and the pulse arrival time (the time the pulse waves need to travel from the LV to the lower limb 14 ) as potential markers of an acute response to cardiac re-synchronization therapy in experimental studies. These results require further clinical validation.…”
Section: Pacing and Ablationmentioning
confidence: 99%